Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer Journal Article
| Authors: | Joshi, S.; Gomes, E. D.; Wang, T.; Corben, A.; Taldone, T.; Gandu, S.; Xu, C.; Sharma, S.; Buddaseth, S.; Yan, P.; Chan, L. Y. L.; Gokce, A.; Rajasekhar, V. K.; Shrestha, L.; Panchal, P.; Almodovar, J.; Digwal, C. S.; Rodina, A.; Merugu, S.; Pillarsetty, N. V. K.; Miclea, V.; Peter, R. I.; Wang, W.; Ginsberg, S. D.; Tang, L.; Mattar, M.; de Stanchina, E.; Yu, K. H.; Lowery, M.; Grbovic-Huezo, O.; O’Reilly, E. M.; Janjigian, Y.; Healey, J. H.; Jarnagin, W. R.; Allen, P. J.; Sander, C.; Erdjument-Bromage, H.; Neubert, T. A.; Leach, S. D.; Chiosis, G. |
| Article Title: | Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer |
| Abstract: | Cancer cell plasticity due to the dynamic architecture of interactome networks provides a vexing outlet for therapy evasion. Here, through chemical biology approaches for systems level exploration of protein connectivity changes applied to pancreatic cancer cell lines, patient biospecimens, and cell- and patient-derived xenografts in mice, we demonstrate interactomes can be re-engineered for vulnerability. By manipulating epichaperomes pharmacologically, we control and anticipate how thousands of proteins interact in real-time within tumours. Further, we can essentially force tumours into interactome hyperconnectivity and maximal protein-protein interaction capacity, a state whereby no rebound pathways can be deployed and where alternative signalling is supressed. This approach therefore primes interactomes to enhance vulnerability and improve treatment efficacy, enabling therapeutics with traditionally poor performance to become highly efficacious. These findings provide proof-of-principle for a paradigm to overcome drug resistance through pharmacologic manipulation of proteome-wide protein-protein interaction networks. © 2021, The Author(s). |
| Journal Title: | Communications Biology |
| Volume: | 4 |
| ISSN: | 2399-3642 |
| Publisher: | Springer Nature |
| Date Published: | 2021-11-25 |
| Start Page: | 1333 |
| Language: | English |
| DOI: | 10.1038/s42003-021-02842-3 |
| PROVIDER: | scopus |
| PMCID: | PMC8617294 |
| PUBMED: | 34824367 |
| DOI/URL: | |
| Notes: | Article -- MSK authors Gokce Askan's first and last names are reversed on the original publication -- MSK authors Liza Shrestha's first names is misspelled on the original publication -- Export Date: 3 January 2022 -- Source: Scopus |
Altmetric
Citation Impact
MSK Authors
Related MSK Work